U.S., Feb. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07398170) titled 'Search for Circulating Tumour Cells in the Blood and/or Cerebrospinal Fluid in Patients With Recurrent Aggressive Meningiomas: Proof-of-concept Study' on Feb. 02.
Brief Summary: The goal of the clinical trial is to assess the presence of circulating tumor cells (CTCs) in the blood and/or cerebrospinal fluid (CSF) of patients with aggressive recurrent meningiomas.
Study Start Date: March, 2026
Study Type: INTERVENTIONAL
Condition:
Meningioma
Intervention:
OTHER: Blood sampling
At the diagnosis of meningioma recurrence: a blood sample of 28 mL of whole blood (i.e., 4 EDTA tubes of 7 mL each) and at the end of meningioma recurre...